Joe Lennerz was appointed as the Chief Scientific Officer at BostonGene
Quoting Joe Lennerz, Chief Scientific Officer at BostonGene, on LinkedIn:
”Some brief personal news. I’ve transitioned from my fulfilling role as Medical Director at Massachusetts General Hospital to become the Chief Scientific Officer (CSO) at BostonGene. The decision wasn’t easy and the chance to contribute to groundbreaking work in a new capacity was too compelling to resist.
I want to express my gratitude to the entire team at MGH who have been not just colleagues but friends and mentors throughout my time there. The experiences and memories we’ve shared are invaluable, and I am proud to have been a part of such a talented group. I want to thank each and everyone of you for contributing to improving patient care.
As many of you know, I have worked with BostonGene for a few years now and the prospect of leading transformative initiatives in this dynamic organization is very exciting. The compassion and dedication of the BG team is astounding and I am thrilled to be part of this team and bring my skills and passion for innovation.
Looking forward to catching up soon.”
Source: Joe Lennerz/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023